Oppenheimer Maintains Their Buy Rating on Prevail Therapeutics (PRVL)

 

Oppenheimer Maintains Their Buy Rating on Prevail Therapeutics (PRVL)

Olson covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals, ACADIA Pharmaceuticals, and Enanta Pharmaceuticals. Prevail Therapeutics has an analyst consensus of Strong Buy …

More Oppenheimer Maintains Their Buy Rating on Prevail Therapeutics (PRVL) Videos

Leave a Reply